Evidence map›Paper›PMID 20618932›Full record

ArticleBMC infectious diseases2010

A prospective descriptive study of cryptococcal meningitis in HIV uninfected patients in Vietnam - high prevalence of Cryptococcus neoformans var grubii in the absence of underlying disease.

Tran Th Chau, Nguyen H Mai, Nguyen H Phu, Ho D Nghia, Ly V Chuong, Dinh X Sinh, Van A Duong, Pham T Diep, James I Campbell, Stephen Baker and 4 more

2 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 69 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed, 2 pooled it
4.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03112031 phase2completednot on this mapstarted 2017, after this paper: background citation

A Randomized Trial of Tamoxifen Combined With Amphotericin B and Fluconazole for Cryptococcal Meningitis

TypeinterventionalSponsorOxford University Clinical Research Unit, VietnamRan2017 to 2018Enrolled50ConditionsMeningitis Streptococcal, Hiv, Meningitis, MeningoencephalitisArmsTamoxifen, Amphotericin B, Fluconazole
NCT06178627 phase4enrolling by invitationnot on this mapstarted 2023, after this paper: background citation

A Multi-center, Prospective, Randomized Trial of Amphotericin B in the Initial Antifungal Therapy for Non-HIV Cryptococcal Meningitis Patients

TypeinterventionalSponsorHuashan HospitalRan2023 to 2026Enrolled250ConditionsCryptococcal Meningitis, Antifungal AgentsArmsAmphotericin B 0.5 mg/kg/day i.v. combined with flucytosine four times per day orally for the first 4 weeks., Amphotericin B 0.7 mg/kg/day i.v. combined with flucytosine four times per day orally for the first 4 weeks.
3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 2 syntheses or guidelines pooled it, 122 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. mBio · 2024
    Article
  10. Chitosan-Deficient Cryptococcus as Whole-Cell Vaccines.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  11. Cryptococcal meningitis.Nature reviews. Disease primers · 2023
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Importance of Clinical Isolates inJournal of fungi (Basel, Switzerland) · 2023
    Review
  17. Article
  18. ExploringJournal of fungi (Basel, Switzerland) · 2022
    Article
  19. Pulmonary Cryptococcosis.Journal of fungi (Basel, Switzerland) · 2022
    Review
  20. Review

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 2 countries.

Tran Th ChauHospital for Tropical Diseases, Quan, Ho Chi Minh City, Vietnam.
Nguyen H Mai
Nguyen H Phu
Ho D Nghia
Ly V Chuong
Dinh X Sinh
Van A Duong
Pham T Diep
James I Campbell
Stephen Baker
Tran T Hien
David G Lalloo
Jeremy J Farrar
Jeremy N Day
Hospital for Tropical Diseases · VNOxford University Clinical Research Unit · VNLiverpool School of Tropical Medicine · GBNuffield Orthopaedic Centre · GBUniversity of Oxford · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMost cases of cryptococcal meningitis occur in patients with HIV infection: the course and outcome of disease in the apparently immunocompetent is much more poorly understood. We describe a cohort of HIV uninfected Vietnamese patients with cryptococcal meningitis in whom underlying disease is uncommon, and relate presenting features of patients and the characteristics of the infecting species to outcome.

methodsA prospective descriptive study of HIV negative patients with cryptococcal meningitis based at the Hospital for Tropical Diseases, Ho Chi Minh City. All patients had comprehensive clinical assessment at baseline, were cared for by a dedicated study team, and were followed up for 2 years. Clinical presentation was compared by infecting isolate and outcome.

results57 patients were studied. Cryptococcus neoformans var grubii molecular type VN1 caused 70% of infections; C. gattii accounted for the rest. Most patients did not have underlying disease (81%), and the rate of underlying disease did not differ by infecting species. 11 patients died while in-patients (19.3%). Independent predictors of death were age > or = 60 years and a history of convulsions (odds ratios and 95% confidence intervals 8.7 (1 - 76), and 16.1 (1.6 - 161) respectively). Residual visual impairment was common, affecting 25 of 46 survivors (54.3%). Infecting species did not influence clinical phenotype or outcome. The minimum inhibitory concentrations of flucytosine and amphotericin B were significantly higher for C. neoformans var grubii compared with C. gattii (p < 0.001 and p = 0.01 respectively).

conclusionIn HIV uninfected individuals in Vietnam, cryptococcal meningitis occurs predominantly in people with no clear predisposing factor and is most commonly due to C. neoformans var grubii. The rates of mortality and visual loss are high and independent of infecting species. There are detectable differences in susceptibility to commonly used antifungal drugs between species, but the clinical significance of this is not clear.

Indexed as

AdolescentAdultAgedAmphotericin BAntifungal AgentsCryptococcus gattiiCryptococcus neoformansFemaleFlucytosineHIV InfectionsHumansMaleMeningitis, CryptococcalMicrobial Sensitivity TestsMiddle AgedPrevalenceAmphotericin BAntifungal AgentsFlucytosine

Identifiers

PMID20618932
PMCPMC2910700
OpenAlexW2038378127

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.